Related references
Note: Only part of the references are listed.Melanin: Quantification and protection against oxidative stress in chromoblastomycosis agents
Daiane Heidrich et al.
MEDICAL MYCOLOGY (2019)
Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment
Elisabeth Maurer et al.
MEDICAL MYCOLOGY (2019)
Defective cytokine production from monocytes/macrophages of E-beta thalassemia patients in response to Pythium insidiosum infection
Somkiat Ud-naen et al.
IMMUNOBIOLOGY (2019)
Prevalence and antifungal susceptibility of Sporothrix species in Jiangxi, central China
Jie Li et al.
MEDICAL MYCOLOGY (2019)
Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents.
Leila M. Lopes-Bezerra et al.
MEDICAL MYCOLOGY (2018)
Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus
Yu-Wen Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Complex Interaction of Deferasirox and Pythium insidiosum: Iron-Dependent Attenuation of Growth In Vitro and Immunotherapy-Like Enhancement of Immune Responses In Vivo
Regis A. Zanette et al.
PLOS ONE (2015)
Risk factors for mortality in patients with mucormycosis
Brad Spellberg et al.
MEDICAL MYCOLOGY (2012)
Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment
Flavio Queiroz-Telles et al.
MEDICAL MYCOLOGY (2011)
Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection
Ronen Ben-Ami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ashraf S. Ibrahim et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole
Ana Raquel Mano Meinerz et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2007)
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases
L Trilles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)